Pfizer acquires Bamboo Therapeutics to beef up gene therapy arsenal

Aug 1 (Reuters) - Pfizer Inc said it had acquired

privately held gene therapy developer Bamboo Therapeutics Inc in

a deal worth up to $645 million to boost its presence in the

treatment of rare...

Read more